Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Premium Research
Premium Research
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Inside the FDA: Why The Pfizer, Inc. (NYSE:PFE) Boxed Warning On Chantix Is Unlikely To Be Removed
David Rich
-
September 16, 2016
Inside the FDA: Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s Psoriasis Drug, Brodalumab.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
Inside The FDA: Why Cempra Inc (NASDAQ:CEMP) Solithromycin Yes Vote Isn’t The Whole Story
Inside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA Agree?
The Top Four Diabetes Best Sellers and One Oral Insulin Pill...
David Rich
-
June 22, 2016
0
Inside the FDA: Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s Psoriasis Drug, Brodalumab.
-
October 8, 2016
2
Inside The FDA: Eli Lilly and Co (NYSE:LLY) Jardiance Aims at...
David Rich
-
September 9, 2016
0
Inside the FDA: Insys Therapeutics Inc. (NASDAQ:INSY) and Sublingual Naloxone
Rafi Farber
-
September 30, 2016
0
